Mikael Ørem, one of the two newest members to VBI's Scientific Advisory Board, will intoduce his company, Ventac Partners, and discuss bridging the gap between discovery and commercialization on Monday, February 6, from 10:30-11:30am.  The presentation is free and open to the public.

Ventac Partners is a dedicated life science consulting firm with offices in the USA, Europe, and Asia. 

Ventac Partners has a strong track record in founding new innovative companies, strategic and operational market and product analysis, intellectual property development, fund raising, licensing, M&A and strategy consulting. All partners are experienced executives from pharma, biotech and medtech companies, with extensive backgrounds in successfully starting, growing and expanding international life science companies.  Several partners have “hands-on” expertise in preclinical, clinical, regulatory, and intellectual property areas.  This expertise brings focus to companies of all sizes seeking an edge in today’s competitive life science marketplace.


Further information can be found on: http://www.ventac-partners.com

 

Ørem's talk will focus on these three main areas:

(1)   Ventac Partners:  Business Strategies and Track Record

(2)   Life Science Entrepeneurs:  Company Building and Venture Capital Funding

(3)   Ventac Partners:  The Future of Funding

February 03, 2012